ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "radiography and rheumatoid arthritis (RA)"

  • Abstract Number: 2059 • 2015 ACR/ARHP Annual Meeting

    Tumor Necrosis Factor Inhibitor Tapering Induced Radiographic Progression Is Driven By Weighted Mean Disease Activity over Time, Not Flaring or Lower TNFi Exposition

    Alfons A. den Broeder1, Chantal A.M. Bouman1, Aatke van der Maas2, Frank H.J. van den Hoogen1, Noortje van Herwaarden1 and R. Landewe3, 1Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 2Hengstdal 3, Sint Maartenskliniek, Nijmegen, Netherlands, 3Department of Internal Medicine, Division of Rheumatology, University Hospital Maastricht, Maastricht, Netherlands

    Background/Purpose: DRESS, a randomized controlled strategy trial (RCT)1investigating disease activity guided tapering of etanercept and adalimumab compared to usual care in RA patients, indicated that…
  • Abstract Number: 2589 • 2015 ACR/ARHP Annual Meeting

    Associations Between 49 Susceptibility SNPs and Disease Activity Including Radiographic Damage in Early Untreated Rheumatoid Arthritis

    Christian G. Ammitzbøll1, Rudi Steffensen2, Martin Bøgsted3,4, Kaspar Rene Nielsen2, Torkell Ellingsen5, Merete Lund Hetland6, Peter Junker5, Jan Pødenphant7, Mikkel Østergaard8, Julia Johansen9, Kim Hørslev-Petersen10 and Kristian Stengaard-Pedersen1, 1Department of Rheumatology, Aarhus University Hospital, Aarhus, Denmark, 2Department of Clinical Immunology, Aalborg University Hospital, Aalborg, Denmark, 3Department of Haematology, Aalborg University Hospital, Aalborg, Denmark, 4Department of Mathematical Sciences, Aalborg University, Aalborg, Denmark, Aalborg, Denmark, 5Department of Rheumatology, Odense University Hospital, Odense, Denmark, 6DANBIO, Center for Rheumatology and Spine Diseases, Rigshospitalet, Glostrup, Glostrup, Denmark, 7Department of Rheumatology, Copenhagen University Hospital at Gentofte, Glostrup, Denmark, 8Rigshospitalet-Glostrup, Copenhagen Center for Arthritis Research, Center for Rheumatology and Spine Diseases, Rigshospitalet - Glostrup, Glostrup, Denmark, 9Departments of Medicine and Oncology, Copenhagen University Hospital at Herlev, Copenhagen, Denmark, 10Rheumatology, Research Unit at King Christian X Hospital for Rheumatic Diseases, Graasten, Graasten, Denmark

    Background/Purpose: Genome-wide association studies (GWAS) and meta-GWAS studies have identified >50 single nucleotide-polymorphisms (SNPs) that are associated with susceptibility to rheumatoid arthritis (RA). It is,…
  • Abstract Number: 2601 • 2015 ACR/ARHP Annual Meeting

    The Multi-Biomarker Disease Activity Score in a TNF Inhibitor Tapering Study in Rheumatoid Arthritis Patients: Predictive Value for Successful Tapering, Flaring and Radiographic Progression

    Chantal A.M. Bouman1, Aatke van der Maas1, Noortje van Herwaarden1, Eric H. Sasso2, Frank H.J. van den Hoogen1 and Alfons A. den Broeder1, 1Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 2Crescendo Bioscience Inc., South San Francisco, CA

    Background/Purpose: We evaluated the predictive value of the multi-biomarker disease activity (MBDA) score for clinical outcomes and radiographic progression in a TNFi tapering study in…
  • Abstract Number: 2693 • 2015 ACR/ARHP Annual Meeting

    Comparing Eight Year Clinical and Radiographic Outcome in Two Cohorts of Patients with Rheumatoid Arthritis

    Maria LE Andersson1, Kristina Forslind2 and Ingiäld Hafström3, 1R&D Centre Spenshult,Halmstad, Halmstad, Sweden, 2Department of Medicine, Helsingborgs Lasarett, Section of Rheumatology, Helsingborg, Sweden, 3Rheumatology Dept, Karoliska Institute, Stockholm, Sweden

    Background/Purpose: To compare patient and disease characteristics over the first 8 years of disease in a large inception cohort of early RA patients included 1992…
  • Abstract Number: 350 • 2015 ACR/ARHP Annual Meeting

    Atypical Femur Fracture in Rheumatoid Arthritis Patients Treated with Bisphosphonates: A Nested Case-Control Study

    JungHee Koh1, Ji Hyeon Ju2, Min Kyung Chung3, Ji Hun Kim3, Seung Min Jung4, Ji Yeon Lee2, Jennifer Lee3, Seung-Ki Kwok5 and Sung-Hwan Park3, 1Seochogu, Banpodaero, 222, Division of Rheumatology, Department of Internal Medicine, College of Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea, 2Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea, 3Division of Rheumatology, Department of Internal Medicine, College of Medicine, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, South Korea, 4Division of Rheumatology, Department of Internal Medicine, school of medicine, The catholic university of Korea, Seoul, South Korea, 5[email protected], Division of Rheumatology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Seoul, South Korea

    Background/Purpose: Patients with rheumatoid arthritis (RA) are diagnosed with osteoporosis earlier than and those without RA, and are therefore exposed to Bisphosphonates (BPs) for longer.…
  • Abstract Number: 439 • 2015 ACR/ARHP Annual Meeting

    Progression of Radiographic Joint Destruction in Patients with Rheumatoid Arthritis Treated with a Biologic Agent in Combination with Methotrexate Versus a Biologic Alone: A Systematic Review and Meta-Analysis of Randomized Trials

    Tanja Schjødt Jørgensen1, Simon Tarp1, Daniel E. Furst2, Anna Døssing1, Peter C. Taylor3, Henning Bliddal1 and Robin Christensen1, 1Musculoskeletal Statistics Unit, The Parker Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg, Copenhagen, Denmark, 2Medicine, University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, CA, 3Nuffield Dept. of Orthopaedics, Rheumatology and Musculoskeletal, Sciences, Kennedy Institute of Rheumatology, University of Oxford,, Oxford, United Kingdom

    Background/Purpose : One of the frequently claimed advantages of biologic agents is their potential to arrest radiographic progression. The ability of disease-modifying antirheumatic drugs (DMARDs;…
  • Abstract Number: 462 • 2015 ACR/ARHP Annual Meeting

    Radiographic Progression in Patients with Early Rheumatoid Arthritis Has Not Become Milder over the Past Decades

    Carola Wassenberg1, Rolf Rau2, Siegfried Wassenberg3, Dietmar Krause4 and Christoph Fiehn5, 1Radiology, Friedrich Ebert Krankenhaus, Neumünster, Germany, 2Expert in Rheumatology, Düsseldorf, Germany, 3Rheumaklinik, Themistocles Gluck hospital - Rheumazentrum Ratingen, Ratingen, Germany, 4Dept. for Medical Informatics, Biometry and Epidemiology, Ruhr University, Bochum, Germany, 5ACURA Centre for Rheumatic Diseases, Baden-Baden, Germany

    Background/Purpose: Retrospective studies have promoted the idea that RA has become a milder disease over the past decades[i], [ii]. These findings are questionable because of…
  • Abstract Number: 1310 • 2015 ACR/ARHP Annual Meeting

    Efficacy of Abatacept in Patients with Rheumatoid Arthritis Assessed By MRI Scans of Bilateral Hands

    Yuji Kukida1, Akiko Kasahara1, Takahiro Seno1,2, Yu Isoda1, Tomoya Sagawa1, Takuya Inoue1, Naoka Kamio1, Risa Sagawa1, Takashi Kida1, Amane Nakabayashi1, Hidetake Nagahara3, Ken Murakami1, Aihiro Yamamoto1, Satoshi Morita4, Hirotoshi Ito5, Masataka Kohno1 and Yutaka Kawahito1, 1Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, 2Department of Rheumatic Diseases and Joint Function, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, 3Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, 4Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan, 5Department of Radiology, Kajiicho Medical Imaging Center, Kyoto, Japan

    Background/Purpose: Previous radiographic and MRI studies have demonstrated that abatacept (ABT) can inhibit the progression of bone and joint destruction in patients with rheumatoid arthritis…
  • Abstract Number: 1321 • 2015 ACR/ARHP Annual Meeting

    Inter-Reader Agreement of a Novel Method of Radiographic Scoring of Rheumatoid Arthritis

    Priyanka Vashisht1, Abhijeet Danve2, Harlan Sayles3, Ted R. Mikuls3 and Alan R. Erickson4, 1Division of Rheumatology and Department of Immunology, University of Nebraska Medical Center, Omaha, NE, 2Rheumatology, University of Nebraska Medical Center, Omaha, NE, 3University of Nebraska Medical Center, Omaha, NE, 4Omaha VA Medical Center and University of Nebraska Medical Center, Omaha, NE

     Background/Purpose: Although widely used in research studies, most of the radiographic scoring systems for Rheumatoid Arthritis (RA) are not feasible in routine clinical practice as…
  • Abstract Number: 1324 • 2015 ACR/ARHP Annual Meeting

    Simplified Larsen Erosion Score Is Compatible with the Classic Larsen Score but Less Time Consuming in Practice

    Michael Ziegelasch1, Alf Kastbom2, Thomas Skogh3, Kristina Forslind4 and Alf Kastbom, 1Rheumatology Department, Rheumatology/AIR, Linkoping, Sweden, 2Department of Clinical and Experimental Medicine, Rheumatology/AIR, Linköping, Sweden, 3IKE/Rheumatology, Linköping University, Linköping, Sweden, 4Department of Medicine, Helsingborgs Lasarett, Section of Rheumatology, Helsingborg, Sweden

    Background/Purpose: Untreated rheumatoid arthritis (RA) often leads to joint space narrowing (JSN) and erosions in synovial joints. Scoring systems like Sharp van der Heijde and…
  • Abstract Number: 2131 • 2014 ACR/ARHP Annual Meeting

    the Impact of Patient-Reported Flares on Radiographic Progression in Rheumatoid Arthritis Patients with Low-Disease Activity: Secondary Analyses from a Randomized Trial

    Dorota Kuettel1, Jette Primdahl2,3,4,5, Lykke Midtbøll Ørnbjerg6, Hans Christian Horn7, Robin Christensen8 and Kim Hørslev-Petersen9, 1Rheumatological, King Christian X's Hospital for Rheumatic Diseases, Graasten, Denmark, 2Rheumatology, King Christian X's Hospital for Rheumatic Diseases, Graasten, Denmark, 3Institute for Regional Health Research, University of Southern Denmark, Graasten, Denmark, 4Hospital of Southern Jutland, Soenderborg, Denmark, 5Danbio Registry, Glostrup, Denmark, 6Copenhagen Center for Arthritis Reasearch, Center for Rheumatology and Spine diseases, Glostrup Hospital, Copenhagen, Denmark, 7Internal Medicine/Rheumatology, Odense University Hospital, Odense, Denmark, 8Rheumatology, MSU, The Parker Institute, Copenhagen University Hospital, Frederiksberg, Denmark, 9Research Unit at King Christian X Hospital for Rheumatic Diseases, Graasten, Denmark

    Background/Purpose Flares, potentially disabling and disease worsening even when a patient is in low disease activity, are common features in patients with rheumatoid arthritis (RA)…
  • Abstract Number: 2137 • 2014 ACR/ARHP Annual Meeting

    Linear Extrapolation of Missing Radiographic Progression Scores Does Not Spuriously overestimate overall Radiographic Progression in Rheumatoid Arthritis

    Iris Markusse1, Robert Landewé2,3, Meilien Ho4, Martin Jenkins4 and Desiree van der Heijde5, 1Leiden University Medical Center, Leiden, Netherlands, 2Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands, 3Atrium Medical Center, Heerlen, Netherlands, 4AstraZeneca R&D Alderley Park, Macclesfield, United Kingdom, 5Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose : Linear Extrapolation (LE) is a frequently applied method to impute missing radiographic data in trials. However, there is frequent critique that LE overestimates…
  • Abstract Number: 1890 • 2014 ACR/ARHP Annual Meeting

    Consistent Inhibition of Bone Destruction By Denosumab in Important Subgroups of Japanese Patients with Rheumatoid Arthritis

    Naoki Ishiguro1, Yoshiya Tanaka2, Hisashi Yamanaka3, Toshiyuki Yoneda4, Takeshi Ohira5, Naoki Okubo6, Harry K. Genant7, Desiree van der Heijde8 and Tsutomu Takeuchi9, 1Orthopaedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine, Nagoya, Japan, 2University of Occupational and Environmental Health, Japan, Kitakyushu, Japan, 3Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, 4Indiana University School of Medicine, Indianapolis, IN, 5Daiich Sankyo Co. Ltd, Tokyo, Japan, 61-2-58, Hiromachi, Daiichi Sankyo Co. Ltd, Tokyo, Japan, 7University of California, San Francisco, CCBR-Synarc, Newark, Tiburon, CA, 8Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 9Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan

    Background/Purpose Denosumab is a fully human monoclonal antibody (IgG2 subclass) that binds specifically to RANKL, inhibits osteoclast-induced bone resorption by preventing the binding of RANKL…
  • Abstract Number: 1474 • 2014 ACR/ARHP Annual Meeting

    Anti-Peptidyl Arginine Deiminase 4 Antibodies in African-Americans with Rheumatoid Arthritis and  Radiographic Scores

    Iris Navarro-Millan1, Andrew Westfall2, Erika Darrah3,4, Antony Rosen5, Ted R. Mikuls6, Richard Reynolds2, Maria I. Danila7, Jeffrey R. Curtis2 and S. Louis Bridges Jr.2,8, 1Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2University of Alabama at Birmingham, Birmingham, AL, 3Division of Rheumatology, The Johns Hopkins University, Baltimore, MD, 45200 Eastern Ave MFL Bldg Cntr, The Johns Hopkins University, Division of Rheumatology, Baltimore, MD, 5Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 6Veteran Affairs Nebraska Western Iowa Health Care System and University of Nebraska Medical Center, Omaha, NE, 7Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 8Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: The presence of serum autoantibodies to peptidyl arginine deiminase 4 (PAD4) have been associated with erosive rheumatoid arthritis (RA) in populations that were composed…
  • Abstract Number: 1431 • 2014 ACR/ARHP Annual Meeting

    Influence of Radiographic Joint Damage in Mortality Risk in a Cohort of Rheumatoid Arthritis Patients: A 20 Years Survival Study

    L. Rodriguez-Rodriguez1,2, J. Ivorra-Cortes3, Lydia Abasolo1,4, Leticia Leon1,4, Oscar Fontsere5, B. Fernández-Gutiérrez1,5 and Juan A Jover1,4, 1Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain, 2Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, 3Rheumatology, University Hospital la Fe, Valencia, Spain, 4Rheumatology, Hospital Clinico San Carlos, Madrid, Spain, 5Rheumatology, Hospital Clínico San Carlos, Madrid, Spain

    Background/Purpose Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased mortality and reduced life expectancy compared with the general population. This mortality gap…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology